Literature DB >> 8276791

Molecular characterization of hasA from an operon required for hyaluronic acid synthesis in group A streptococci.

B A Dougherty1, I van de Rijn.   

Abstract

The mechanism by which group A streptococci produce the antiphagocytic hyaluronate (hyaluronic acid) capsule is incompletely understood. Enzymes known to be essential for synthesis of this polysaccharide include the membrane-associated hyaluronate synthase as well as those required for production of the substrate sugars UDP-N-acetylglucosamine and UDP-glucuronic acid. In this study, a Tn916 insertion that inactivates hyaluronate synthetic activity was localized to a gene designated hasA in the hyaluronic acid synthesis operon. This gene has recently been preliminarily identified as the group A streptococcal hyaluronate synthase. The DNA sequence and transcription start site of hasA were determined, and the predicted HasA protein was shown to have characteristics of a membrane protein. Amino acid sequence homology suggests that HasA is related to a family of proteins involved in polysaccharide production and cell differentiation. Finally, in addition to the loss of hyaluronate synthase activity, the hasA::Tn916 insertion was demonstrated to correlate with a loss of UDP-glucuronic acid dehydrogenase activity. These results suggest that the genes required for hyaluronate synthase activity and production of the UDP-glucuronic acid substrate are transcribed as a unit in group A streptococci.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8276791

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  Role of CsrR, hyaluronic acid, and SpeB in the internalization of Streptococcus pyogenes M type 3 strain by epithelial cells.

Authors:  Jeries Jadoun; Osnat Eyal; Shlomo Sela
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

2.  Demonstration of UDP-glucose dehydrogenase activity in cell extracts of Escherichia coli expressing the pneumococcal cap3A gene required for the synthesis of type 3 capsular polysaccharide.

Authors:  C Arrecubieta; E García; R López
Journal:  J Bacteriol       Date:  1996-05       Impact factor: 3.490

3.  Differential expression of genes in the vir regulon of Streptococcus pyogenes is controlled by transcription termination.

Authors:  K H Pritchard; P P Cleary
Journal:  Mol Gen Genet       Date:  1996-02-05

Review 4.  Multidomain architecture of beta-glycosyl transferases: implications for mechanism of action.

Authors:  I M Saxena; R M Brown; M Fevre; R A Geremia; B Henrissat
Journal:  J Bacteriol       Date:  1995-03       Impact factor: 3.490

5.  Structure of the has operon promoter and the effect of mutations on the has promoter strength in Streptococcus equi subsp. zooepidemicus.

Authors:  Ján Krahulec; Marcela Tlustá; Stanislav Stuchlík; Ján Turňa
Journal:  Mol Biotechnol       Date:  2011-10       Impact factor: 2.695

6.  Capsular Polysaccharide of Group A Streptococcus.

Authors:  Michael R Wessels
Journal:  Microbiol Spectr       Date:  2019-01

Review 7.  Bacterial polymers: biosynthesis, modifications and applications.

Authors:  Bernd H A Rehm
Journal:  Nat Rev Microbiol       Date:  2010-06-28       Impact factor: 60.633

8.  Characterization of genes in the cellulose-synthesizing operon (acs operon) of Acetobacter xylinum: implications for cellulose crystallization.

Authors:  I M Saxena; K Kudlicka; K Okuda; R M Brown
Journal:  J Bacteriol       Date:  1994-09       Impact factor: 3.490

9.  A conserved UDP-glucose dehydrogenase encoded outside the hasABC operon contributes to capsule biogenesis in group A Streptococcus.

Authors:  Jason N Cole; Ramy K Aziz; Kirsten Kuipers; Anjuli M Timmer; Victor Nizet; Nina M van Sorge
Journal:  J Bacteriol       Date:  2012-09-07       Impact factor: 3.490

10.  Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection.

Authors:  C D Ashbaugh; H B Warren; V J Carey; M R Wessels
Journal:  J Clin Invest       Date:  1998-08-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.